Healthcare Costs and Resource Use of Patients with Dupuytren Contracture Treated with Collagenase Clostridium Histolyticum or Fasciectomy: A Propensity Matching Analysis
Vladimir Zah,1 Jovana Pelivanovic,1 Simona Tatovic,1 Djurdja Vukicevic,1 Martina Imro,1 Jane Ruby,2 David Hurley2 1Health Economics and Outcomes Research Department, ZRx Outcomes Research Inc., Mississauga, ON, Canada; 2Medical Affairs, Endo Pharmaceuticals Inc., Malvern, PA, USACorrespondence: Vlad...
Saved in:
Main Authors: | Zah V (Author), Pelivanovic J (Author), Tatovic S (Author), Vukicevic D (Author), Imro M (Author), Ruby J (Author), Hurley D (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2020-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Healthcare Costs and Resource Use of Patients with Dupuytren Contracture Treated with Collagenase Clostridium Histolyticum or Fasciectomy: A Propensity Matching Analysis [Corrigendum]
by: Zah V, et al.
Published: (2021) -
The emerging role of Clostridium histolyticum collagenase in the treatment of Dupuytren disease
by: Alexis Thomas, et al.
Published: (2010) -
Optimization of Col H Gene Encoding Clostridium histolyticum Collagenase to Express in Escherichia coli
by: Seyed Mohammad Amin Mahdian, et al.
Published: (2022) -
The efficacy and safety of intralesional injection of collagenase Clostridium histolyticum for Peyronie's disease: A meta-analysis of published prospective studies
by: Fuxun Zhang, et al.
Published: (2022) -
Clostridium histolyticum (AA4500) for the Treatment of Adhesive Capsulitis of the Shoulder: A Randomised Double-Blind, Placebo-Controlled Study for the Safety and Efficacy of Collagenase – Single Site Report
by: Fitzpatrick J, et al.
Published: (2020)